• PacBio entered a compatibility collaboration with Lucid Genomics to support tertiary analysis for data generated on PacBio long-read sequencing instruments.
• Lucid Genomics joined PacBio Compatible partner program, positioning its platform as validated software for downstream analysis of HiFi sequencing data.
• Partnership aims to speed conversion of long-read sequencing output into clinical or research insights through integrated variant interpretation workflows.
• Companies plan joint customer engagements, technical enablement, and co-marketing to expand adoption of HiFi sequencing workflows.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pacific Biosciences of California Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604210905PRIMZONEFULLFEED9693713) on April 21, 2026, and is solely responsible for the information contained therein.